11 Best Stocks To Invest In For Grandchildren

Page 2 of 11

10. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 106   

Eli Lilly and Company (NYSE:LLY) develops and markets human pharmaceuticals. In January the company announced that the US Food and Drug Administration had approved Omvoh for the treatment of moderately to severely active Crohn’s disease in adults. Omvoh is the first biologic treatment in more than 15 years to have disclosed two-year Phase 3 efficacy data in Crohn’s disease at the time of approval. Daniel Skovronsky, the president of Lilly Research Laboratories and Lilly Immunology, stated that Omvoh offers more patients a treatment option that can provide long-term disease control and relieve key symptoms. The company reported a 45% revenue increase to $13.53 billion in the fourth quarter of 2024, fueled by strong volume growth from Mounjaro and Zepbound.

Page 2 of 11